Clincosm LogoSign in Get a demo

diffuse cutaneous systemic sclerosis

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,

Not yet recruiting
  • Idiopathic Inflammatory Myopathies
  • +3 more
  • (no location specified)
Nov 21, 2023

Diffuse Cutaneous Systemic Sclerosis Trial in United States (Belumosudil)

Completed
  • Diffuse Cutaneous Systemic Sclerosis
  • Los Angeles, California
  • +4 more
Jan 5, 2023

Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in New Orleans (HZN-825)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Sclerosis, Systemic
  • New Orleans, Louisiana
    DelRicht Clinical Research, LLC
Nov 15, 2022

Diffuse Cutaneous Systemic Sclerosis Trial in United States (TEPEZZA, Placebo)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • TEPEZZA
  • Placebo
  • Los Angeles, California
  • +6 more
Jul 22, 2022

Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease Trial in Worldwide (PRA023 IV, Companion diagnostic ( CDx),

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Interstitial Lung Disease
  • PRA023 IV
  • +2 more
  • Los Angeles, California
  • +13 more
Jul 12, 2022

Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in Worldwide (HZN-825 BID, Placebo, HZN-825 QD)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Sclerosis, Systemic
  • HZN-825 BID
  • +2 more
  • Phoenix, Arizona
  • +48 more
Jun 21, 2022

Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc Trial in Canada, United States (Brentuximab Vedotin, Placebo)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • +2 more
  • Brentuximab Vedotin
  • Placebo
  • Los Angeles, California
  • +9 more
May 12, 2022

Systemic Sclerosis, Scleroderma, Diffuse Systemic Sclerosis Trial in Scottsdale (Ixazomib)

Recruiting
  • Systemic Sclerosis
  • +18 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
May 3, 2022

Diffuse Cutaneous Systemic Sclerosis Trial (Brentuximab vedotin)

Not yet recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Brentuximab vedotin
  • (no location specified)
Apr 11, 2022

Systemic scleRosis and Progressive Digital ulcEr Disease.

Recruiting
  • Scleroderma
  • +4 more
    • Athens, Greece
      Laikon Hospital of Athens
    Mar 22, 2022

    Diffuse Cutaneous Systemic Sclerosis Trial in Ann Arbor (FCR001)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • FCR001
    • Ann Arbor, Michigan
      University of Michigan
    Mar 4, 2022

    Diffuse Cutaneous Systemic Sclerosis Trial in London (Brentuximab Vedotin)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Brentuximab Vedotin
    • London, Ontario, Canada
      Rheumatology Clinic, St. Joseph's Health Care
    Feb 3, 2022

    Diffuse Cutaneous Systemic Sclerosis Trial in United States (JBT-101, Placebo, Part B Open-Label Extension)

    Terminated
    Has Results
    • Diffuse Cutaneous Systemic Sclerosis
    • Los Angeles, California
    • +8 more
    Mar 25, 2021

    Diffuse Cutaneous Systemic Sclerosis Trial in Worldwide (Lenabasum 5 mg, Lenabasum 20 mg, Placebo oral capsule)

    Terminated
    • Diffuse Cutaneous Systemic Sclerosis
    • Lenabasum 5 mg
    • +2 more
    • La Jolla, California
    • +73 more
    Mar 25, 2021

    Diffuse Cutaneous Systemic Sclerosis Trial in Worldwide (IgPro10, Placebo)

    Withdrawn
    • Diffuse Cutaneous Systemic Sclerosis
    • IgPro10
    • Placebo
    • Scottsdale, Arizona
    • +76 more
    Nov 16, 2020

    Diffuse Cutaneous Systemic Sclerosis Trial in Canada, United Kingdom, United States (Abatacept, Placebo)

    Completed
    Has Results
    • Diffuse Cutaneous Systemic Sclerosis
    • Los Angeles, California
    • +26 more
    Feb 13, 2020

    Scleroderma, Diffuse, Diffuse Cutaneous Systemic Sclerosis Trial in Worldwide (IVA337, Placebo)

    Completed
    • Scleroderma, Diffuse
    • Diffuse Cutaneous Systemic Sclerosis
    • Pleven, Bulgaria
    • +48 more
    Mar 1, 2019

    Diffuse Cutaneous Systemic Sclerosis Trial in Boston (Mycophenolate Mofetil)

    Completed
    • Diffuse Cutaneous Systemic Sclerosis
    • Mycophenolate Mofetil
    • Boston, Massachusetts
      Boston University School of Medicine
    Mar 29, 2011